Valiant Laboratories Limited IPO

Valiant Laboratories Limited is listed in the MAINBOARD segment with a price band of ₹133 to ₹140. The figures below are as reported by the exchanges and public sources.

Valiant Laboratories Limited IPO — key facts

• The Valiant Laboratories Limited IPO price band is ₹133 to ₹140 per share.
• As of 6 September 2026, the Valiant Laboratories Limited IPO subscription status is 29.76x overall.
• The issue is open from 27-SEP-2023 to 03-OCT-2023.
• Valiant Laboratories Limited listed on 06-OCT-2023.
• Valiant Laboratories Limited listed at ₹169.05. The listing gain was 20.8% against the upper end of the issue price band.

Valiant Laboratories Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹133 – ₹140

Issue size

₹152.46 Cr

Fresh issue

₹152.46 Cr

Opens

27-SEP-2023

Closes

03-OCT-2023

Listing

06-OCT-2023

Total subscription

29.76x

Retail

16.06x

QIB

20.83x

NII

73.64x

Lead managers

Unistone Capital (left lead)

Listing price

₹169.05

Listing day change

+20.8%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.